Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile
Whole-genome sequencing was used to determine whether the reductions in recurrence of <em>Clostridium difficile</em> infection observed with fidaxomicin in pivotal phase 3 trials occurred by preventing relapse of the same infection, by preventing reinfection with a new strain, or by prev...
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Andere auteurs: | |
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
University of Chicago Press
2013
|
| Onderwerpen: |